Skip to main content
An official website of the United States government

recombinant human epidermal growth factor

A recombinant form of the naturally-occurring polypeptide human epidermal growth factor with potential epithelial regenerative and cytoprotective activities. Upon topical application, recombinant human epidermal growth factor (rhEGF) may stimulate epithelial proliferation, differentiation and migration, which may result in the acceleration of epithelial regeneration and wound healing. In addition, rhEGF may attenuate epithelial cytotoxicities related to chemotherapy and/or radiotherapy.
Foreign brand name:EASYEF
Abbreviation:rhEGF
Search NCI's Drug Dictionary